all AI news
A hybrid quantum-classical fusion neural network to improve protein-ligand binding affinity predictions for drug discovery
Feb. 27, 2024, 5:44 a.m. | L. Domingo, M. Chehimi, S. Banerjee, S. He Yuxun, S. Konakanchi, L. Ogunfowora, S. Roy, S. Selvaras, M. Djukic, C. Johnson
cs.LG updates on arXiv.org arxiv.org
Abstract: The field of drug discovery hinges on the accurate prediction of binding affinity between prospective drug molecules and target proteins, especially when such proteins directly influence disease progression. However, estimating binding affinity demands significant financial and computational resources. While state-of-the-art methodologies employ classical machine learning (ML) techniques, emerging hybrid quantum machine learning (QML) models have shown promise for enhanced performance, owing to their inherent parallelism and capacity to manage exponential increases in data dimensionality. Despite …
abstract art arxiv computational cs.lg discovery disease drug discovery financial fusion hybrid influence molecules network neural network prediction predictions protein proteins quant-ph quantum resources state type
More from arxiv.org / cs.LG updates on arXiv.org
Jobs in AI, ML, Big Data
Data Architect
@ University of Texas at Austin | Austin, TX
Data ETL Engineer
@ University of Texas at Austin | Austin, TX
Lead GNSS Data Scientist
@ Lurra Systems | Melbourne
Senior Machine Learning Engineer (MLOps)
@ Promaton | Remote, Europe
Senior ML Engineer
@ Carousell Group | Ho Chi Minh City, Vietnam
Data and Insight Analyst
@ Cotiviti | Remote, United States